Key Takeaways
Extended Takeaways
- Clinical exposure appears to matter: providers encountering problematic gaming “a few times per month to daily” were more likely than those who rarely did to view IGD as clinically significant (95.5% vs 71.1%, P=.025) and to report confidence in recognition (72.7% vs 26.7%, P<.001), management (50.0% vs 15.6%, P=.003), and familiarity with diagnostic criteria (63.6% vs 20.0%, P<.001).
- Higher exposure did not reduce perceived educational gaps; clinicians seeing IGD more often were also more likely to endorse a need for additional training (95.5% vs 66.7%, P=.009), suggesting that real-world encounters may heighten awareness of diagnostic and management complexity.
- Family-facing encounters may be a practical signal for case finding: providers who interacted with concerned family members “occasionally to regularly” reported higher confidence recognizing IGD (68.2% vs 28.9%, P=.002), managing it (45.5% vs 17.8%, P=.016), and greater familiarity with diagnostic criteria (59.1% vs 22.2%, P=.003).
- Referral pathways appear underused in this sample, with 88.1% reporting rarely referring families to IGD-related support services; clinicians may need clearer workflows for when problematic gaming is identified in psychiatry or internal medicine settings.
- Uncertainty about treatment options was common, as 43% were unsure about treatment efficacy; the article specifically points to psychotherapy approaches such as cognitive-behavioral therapy, motivational interviewing, and group-based interventions, while noting there is currently no US Food and Drug Administration–approved pharmacotherapy for IGD.
- Internal medicine may be a particularly important target for screening education because these clinicians often serve as first points of contact, yet only 7.1% reported confidence in recognizing and diagnosing IGD and 7.1% in managing it.
